TSTickerStarGet alerts

ExxonMobil Reports 3Q 2026 Market and Planned Impacts to Earnings Ahead of October 30 Full Results

XOM in_line prior Q3 2026 Corporate and Financing Expenses guidance by an undisclosed amount. ExxonMobil furnished its 3Q 2026 market and planned factors expected to affect results relative to 2Q 2026, with the full earnings release scheduled for October 30, 2026 at approximately 5:30 a.m. CT. The exhibit provides estimated impacts of market factors including a $1.3 billion negative impact from lower liquids prices and a $4.4 billion positive impact from improved margins, with the net margin benefit partially of...

Share this story

Forward guidance

Corporate and Financing ExpensesQ3 2026
$0.8 billion - $1.0 billion

Key takeaways

  • Q3 2026 earnings release scheduled for October 30, 2026 at approximately 5:30 a.m. CT with filing on Form 8-K and posting on www.exxonmobil.com

  • Liquids price decline estimated to negatively impact 3Q earnings by $1.3 billion versus 2Q, while gas price improvement adds an estimated $0.3 billion

  • Improved product margins estimated to add $4.4 billion to 3Q earnings, with Energy Products margin improvement contributing $4.5 billion partially offset by Specialty Products and Chemical margin changes

  • Estimated negative timing effects of $2.5 billion in Energy Products and $2.5 billion total, reflecting mark-to-market accounting on financial derivatives versus physical shipments

  • Other factors including entitlements, sales timing, and tax impacts estimated to negatively impact 3Q by $0.9 billion in Upstream and $0.9 billion total

  • Estimated weighted-average common shares outstanding of approximately 4,140 million (assuming dilution)

  • Corporate and Financing Expenses guidance maintained at $0.8-$1.0 billion for 3Q 2026, compared to $0.8 billion actual in 2Q 2026

Key metrics

2Q26 GAAP EarningsQ2 2026
$14.5 billion
2Q26 Adjusted Earnings (non-GAAP)Q2 2026
$14.7 billion
2Q26 Upstream Adjusted EarningsQ2 2026
$9.2 billion
2Q26 Energy Products Adjusted EarningsQ2 2026
$4.1 billion
2Q26 Chemical Products Adjusted EarningsQ2 2026
$1.2 billion
2Q26 Specialty Products Adjusted EarningsQ2 2026
$1.0 billion
2Q26 Corp & Fin Adjusted ExpensesQ2 2026
$0.8 billion
Estimated Weighted-Average Common Shares (diluted)Q3 2026
~4,140 million

Primary source

TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.

Open SEC filing

Follow XOM in real time

Get material earnings, filing, IR, and earnings-call alerts by email.

Create a free alert